Novozymes A/S Novozymes A/S

Novozymes A/S

NSIS-B

Rank in Stocks #804
Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global... Established in 1925 and based in Bagsvaerd, Denmark, Novozymes A/S is a global provider of biological solutions, specializing in the development and sale of industrial enzymes, microorganisms, and probiotics. The company's reach extends internationally, serving markets in Denmark, the rest of Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America. Novozymes' diverse portfolio includes protein solutions for the food and beverage sector, alongside a comprehensive suite of cleaning and hygiene offerings for industrial, medical, and household applications, such as drain openers, septic tank treatments, ware washing, and professional laundry. In agriculture, they supply solutions for various crops like corn, cotton, soybeans, and wheat, focusing on bioyield and biocontrol, in addition to animal health and nutrition products and aquaculture systems for warm water species. The company actively supports sustainable industrial processes with contributions to bioenergy (including ethanol, biodiesel, renewable diesel, biogas, and wastewater treatment), biorefining (encompassing fiber modification, bleach boosting, deposit control, starch modification, carbon capture), and applications for textiles and leather. Their extensive range of enzyme solutions, such as lipases, proteases, oxidoreductases, and carbohydrases, are crucial for processes like corn and wheat separation, liquefaction, and saccharification. Furthermore, Novozymes addresses human health with solutions targeting brain, oral, protective, immune, and gastrointestinal well-being, while also engaging in areas like biocatalysis, cell culture, and diagnostics.
Share Price
$73.29
Market Cap
$30.23B
Change (1 day)
1.29%
Change (1 year)
28.48%
Country
DK
Trade Novozymes A/S (NSIS-B)

Category

Basic Materials
Price of NSIS-B with the market cap of B
Novozymes A/S Novozymes A/S
NSIS-B
$73.29
Market Capitalization of Novozymes A/S(NSIS-B)
Market Cap: $30.23B
As of October 2026 Novozymes A/S has a market cap of $30.23B. This makes Novozymes A/S the world's 804th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Novozymes A/S from 2000 to 2026
NSIS-B compared with Top 5 Most Popular stocks
Price of NSIS-B Asset B Mkt. of B Results
Novozymes A/S Novozymes A/S
$19,284.84 $15.64B
$5.286T +33,706.78%
Novozymes A/S Novozymes A/S
$18,243.48 $15.64B
$5.001T +31,881.26%
Novozymes A/S Novozymes A/S
$15,214.86 $15.64B
$4.171T +26,572.02%
Novozymes A/S Novozymes A/S
$14,490.56 $15.64B
$3.972T +25,302.29%
Novozymes A/S Novozymes A/S
$10,363.11 $15.64B
$2.841T +18,066.78%